Xiaoqing Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoqing Han has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Haiyuan Zhang
The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
4 shared publications - Jiao Yan
Guangzhou Medical University
2 shared publications - Panpan Song
The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
2 shared publications Xingbo Wang
School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, China
2 shared publicationsYanjing Wang
The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
2 shared publicationsYaqing Kang
The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 10 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Spin-driven enantioselective regulation of cyclooxygenase-2 activity for rheumatoid arthritis therapy via chiral gold nanohelices
Electron-spin dynamics represent an additional dimension in enzymatic catalysis, where most regulatory strategies focus on modulating active-site chemistry. Here, we present a spintronic approach that employs chiral gold nanohelices (CAu) as electron spin polarizers to enantiospecifically modulate cyclooxygenase-2 (COX-2) activity for rheumatoid arthritis intervention. Exploiting the chirality-induced spin selectivity (CISS) effect inherent to both COX-2 and CAu, we demonstrate that left-handed CAu (Lh-CAu) enhances, whereas right-handed CAu (Rh-CAu) suppresses COX-2 catalytic efficiency via spin-dependent electron transfer at the chiral nanoparticle-enzyme interfaces. To achieve targeted modulation in complex biological settings, we engineer molecularly imprinted CAu (CAu@MIP) for selectively regulating COX-2 in inflammatory cells and collagen-induced arthritis murine model (male DBA/1 J mice). Treatment with Rh-CAu@MIP significantly reduces prostaglandin E2 secretion and mitigates joint inflammation, achieving therapeutic efficacy comparable to conventional COX-2 inhibitors. Our findings introduce electron spin polarization as an orthogonal mechanism for enzymatic regulation, offering a bioelectronic strategy for inflammation-targeted therapy.
- 10 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessSpin-driven enantioselective regulation of cyclooxygenase-2 activity for rheumatoid arthritis therapy via chiral gold nanohelices
Electron-spin dynamics represent an additional dimension in enzymatic catalysis, where most regulatory strategies focus on modulating active-site chemistry. Here, we present a spintronic approach that employs chiral gold nanohelices (CAu) as electron spin polarizers to enantiospecifically modulate cyclooxygenase-2 (COX-2) activity for rheumatoid arthritis intervention. Exploiting the chirality-induced spin selectivity (CISS) effect inherent to both COX-2 and CAu, we demonstrate that left-handed CAu (Lh-CAu) enhances, whereas right-handed CAu (Rh-CAu) suppresses COX-2 catalytic efficiency via spin-dependent electron transfer at the chiral nanoparticle-enzyme interfaces. To achieve targeted modulation in complex biological settings, we engineer molecularly imprinted CAu (CAu@MIP) for selectively regulating COX-2 in inflammatory cells and collagen-induced arthritis murine model (male DBA/1 J mice). Treatment with Rh-CAu@MIP significantly reduces prostaglandin E2 secretion and mitigates joint inflammation, achieving therapeutic efficacy comparable to conventional COX-2 inhibitors. Our findings introduce electron spin polarization as an orthogonal mechanism for enzymatic regulation, offering a bioelectronic strategy for inflammation-targeted therapy.
- Open Access
- 30 November 2025
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
HuB serves as the central hub for connecting HuR-related mRNAs with translation machinery in inflammation
The mRNAs of inflammatory factors often contain unstable AU-rich elements (AREs) within their 3’ untranslated regions (3’UTRs), and HuR is a key ARE-binding protein to recognize such elements. However, the roles of other Hu family member (s) remain unclear. In this study, we show an inflammatory stimulation-induced short-form and cytoplasm-localized HuB (Hel-N2). In cytoplasm, HuB interacts with HuR as well as HuR-associated pro-inflammatory cytokine/chemokine mRNAs and facilitates the recruitment of these mRNAs into the translation machinery. Furthermore, HuB recruits RNA helicase DHX9 to unwind the secondary structures presented in the 5’ untranslated regions (5’UTRs) of these mRNAs, thereby promoting their translation. The work has been carried out in human and mouse cell lines and female mice. Our finding not only broadens our understanding about how the Hu family members govern pro-inflammatory gene expression, but also suggests that targeting HuB is a viable strategy to treat inflammation-related diseases.
- 30 November 2025
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessHuB serves as the central hub for connecting HuR-related mRNAs with translation machinery in inflammation
The mRNAs of inflammatory factors often contain unstable AU-rich elements (AREs) within their 3’ untranslated regions (3’UTRs), and HuR is a key ARE-binding protein to recognize such elements. However, the roles of other Hu family member (s) remain unclear. In this study, we show an inflammatory stimulation-induced short-form and cytoplasm-localized HuB (Hel-N2). In cytoplasm, HuB interacts with HuR as well as HuR-associated pro-inflammatory cytokine/chemokine mRNAs and facilitates the recruitment of these mRNAs into the translation machinery. Furthermore, HuB recruits RNA helicase DHX9 to unwind the secondary structures presented in the 5’ untranslated regions (5’UTRs) of these mRNAs, thereby promoting their translation. The work has been carried out in human and mouse cell lines and female mice. Our finding not only broadens our understanding about how the Hu family members govern pro-inflammatory gene expression, but also suggests that targeting HuB is a viable strategy to treat inflammation-related diseases.
- 2 October 2025
- Published by American Chemical Society (ACS) in ACS Nano
Nebulized Inhalation of Engineered Extracellular Vesicles to Destruct Pre-metastatic Niche and Inhibit Postoperative Lung Metastasis in a Mouse Model
Pre-metastatic niche (PMN) in the distant organs provides a suitable soil for the colonization of circulating tumor cells (CTCs). Targeting PMN destruction is becoming an effective strategy against tumor metastasis. Considering that the lung is the organ with the highest incidence of melanoma metastasis, nebulized inhalation can directly deliver drugs to the lung. Herein, M1 macrophage-derived, CXCR4-overexpressed, and BMS202-loaded extracellular vesicles (BMS@C-M1 EV) were constructed to inhibit postoperative melanoma lung metastasis. After nebulized inhalation, BMS@C-M1 EV effectively accumulated in the lungs of postoperative melanoma mice, its surface CXCR4 could inhibit the recruitment of monocytic myeloid-derived suppressor cells (mo-MDSCs) by consuming CXCL12, and its M1 pro-inflammatory feature repolarized tumor-associated macrophages (TAMs) from the M2 pro-tumor phenotype into the M1 antitumor phenotype, thereby reversing the immunosuppressive microenvironment, activating the T cell immune response, and preventing PMN construction. Furthermore, BMS202 released by BMS@C-M1 EV could induce the dimerization of PD-L1 in CTCs to block the PD-1/PD-L1 interaction, thereby enhancing T cell-mediated immune elimination of CTCs and further inhibiting the occurrence of metastasis. Therefore, BMS@C-M1 EV through nebulized inhalation could disrupt PMN formation and eliminate CTCs in the lung, effectively suppressing postoperative melanoma lung metastasis. This therapeutic approach holds great potential for preventing postoperative melanoma lung metastasis.
- 2 October 2025
- Published by American Chemical Society (ACS) in ACS Nano
Nebulized Inhalation of Engineered Extracellular Vesicles to Destruct Pre-metastatic Niche and Inhibit Postoperative Lung Metastasis in a Mouse Model
Pre-metastatic niche (PMN) in the distant organs provides a suitable soil for the colonization of circulating tumor cells (CTCs). Targeting PMN destruction is becoming an effective strategy against tumor metastasis. Considering that the lung is the organ with the highest incidence of melanoma metastasis, nebulized inhalation can directly deliver drugs to the lung. Herein, M1 macrophage-derived, CXCR4-overexpressed, and BMS202-loaded extracellular vesicles (BMS@C-M1 EV) were constructed to inhibit postoperative melanoma lung metastasis. After nebulized inhalation, BMS@C-M1 EV effectively accumulated in the lungs of postoperative melanoma mice, its surface CXCR4 could inhibit the recruitment of monocytic myeloid-derived suppressor cells (mo-MDSCs) by consuming CXCL12, and its M1 pro-inflammatory feature repolarized tumor-associated macrophages (TAMs) from the M2 pro-tumor phenotype into the M1 antitumor phenotype, thereby reversing the immunosuppressive microenvironment, activating the T cell immune response, and preventing PMN construction. Furthermore, BMS202 released by BMS@C-M1 EV could induce the dimerization of PD-L1 in CTCs to block the PD-1/PD-L1 interaction, thereby enhancing T cell-mediated immune elimination of CTCs and further inhibiting the occurrence of metastasis. Therefore, BMS@C-M1 EV through nebulized inhalation could disrupt PMN formation and eliminate CTCs in the lung, effectively suppressing postoperative melanoma lung metastasis. This therapeutic approach holds great potential for preventing postoperative melanoma lung metastasis.
- Open Access
Construction of Antibacterial MoS2-ACF Phenotype Switcher for Bidirectionally Regulating Inflammation–Proliferation Transition in Wound Healing
The transition between the inflammatory phase and the proliferative phase is critical for wound healing. However, the development of proper switchers that can regulate this transition is facing great challenges. Macrophages play versatile roles in all wound healing phases because they can readily switch from pro-inflammatory M1 phenotypes to anti-inflammatory M2 phenotypes in response to different microenvironment stimuli. Herein, taking advantage of enhanced electron transfer by coupling MoS2 with a highly conductive activated carbon fiber (ACF) network, a MoS2-ACF heterojunction structure was constructed as a macrophage M1-M2 phenotype switcher (MAPS) for regulating inflammation–proliferation transition to accelerate wound healing. In the early stages of wound repair, MAPS-mediated photothermal effects with near-infrared laser irradiation could promote macrophage reprogramming to the M1 phenotype, which can expedite inflammation. NIR photo-induced hyperthermia, together with M1 macrophages, directly and indirectly kills bacteria. Later, during the healing process, the MAPS could further reprogram macrophages towards the M2 phenotype via its inherent reactive oxygen species (ROS) scavenging ability to resolve inflammation, promoting cell proliferation. Therefore, MoS2-ACF heterojunction structures provide a new strategy to modulate inflammation–proliferation transition by rebalancing the immuno-environmental equilibrium of macrophage M1/M2 phenotypes.
Open AccessConstruction of Antibacterial MoS2-ACF Phenotype Switcher for Bidirectionally Regulating Inflammation–Proliferation Transition in Wound Healing
The transition between the inflammatory phase and the proliferative phase is critical for wound healing. However, the development of proper switchers that can regulate this transition is facing great challenges. Macrophages play versatile roles in all wound healing phases because they can readily switch from pro-inflammatory M1 phenotypes to anti-inflammatory M2 phenotypes in response to different microenvironment stimuli. Herein, taking advantage of enhanced electron transfer by coupling MoS2 with a highly conductive activated carbon fiber (ACF) network, a MoS2-ACF heterojunction structure was constructed as a macrophage M1-M2 phenotype switcher (MAPS) for regulating inflammation–proliferation transition to accelerate wound healing. In the early stages of wound repair, MAPS-mediated photothermal effects with near-infrared laser irradiation could promote macrophage reprogramming to the M1 phenotype, which can expedite inflammation. NIR photo-induced hyperthermia, together with M1 macrophages, directly and indirectly kills bacteria. Later, during the healing process, the MAPS could further reprogram macrophages towards the M2 phenotype via its inherent reactive oxygen species (ROS) scavenging ability to resolve inflammation, promoting cell proliferation. Therefore, MoS2-ACF heterojunction structures provide a new strategy to modulate inflammation–proliferation transition by rebalancing the immuno-environmental equilibrium of macrophage M1/M2 phenotypes.
- Open Access
- 24 December 2024
- Published by Elsevier in Materials Today Bio
- Vol. 30, 101429
Multifunctional biosynthesized magnetosome for multimodal imaging and combined therapy of tumor
- 24 December 2024
- Published by Elsevier in Materials Today Bio
- Vol. 30, 101429
Open AccessMultifunctional biosynthesized magnetosome for multimodal imaging and combined therapy of tumor